Evaluation of the Efficacy of Chinese Inactivated COVID-19 Vaccines against the Delta Variant in the Nanjing Outbreak: A Cohort Study
Journal of Respiratory Biology and Translational Medicine · 2024
DOI: 10.70322/jrbtm.2024.10016 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Respiratory Biology and Translational Medicine, 2024. Verfasst von Fuqun Liu und 14 weiteren Autor:innen. Die Arbeit nennt 86 Literaturangaben.
Abstract (Originalsprache)
Background
The strains of COVID-19 are constantly mutating, and the effectiveness of Chinese inactivated vaccines against the COVID-19 Delta variant has not been described clearly.
Methods
The clinical data of patients with the COVID-19 Delta variant in the 2021 Nanjing outbreak were retrospectively reviewed.
Results
There were 212 patients with the COVID-19 Delta variant (unvaccinated, n = 56, 26.42%; vaccinated, n = 156, 73.58%) included in our cohort study. The median age was 45.5 (38, 53) years old. Eighty-seven subjects (41.04%) were airport staff, and 94 patients (44.34%) in 32 families were infected. There were 53 (25.00%) and 103 (48.58%) cases with one-dose and two-dose vaccination, respectively, and 55 (25.94%), 147 (69.34%) and 10 (4.72%) had mild, moderate and severe symptoms, respectively. The duration of viral shedding, or viral shedding time (VST), was significantly longer in unvaccinated individuals compared to vaccinated individuals (p = 0.0008). Moreover, the duration was significantly longer in patients who received one vaccine dose than those who received two doses (p
Zitieren
APA
Liu, F., Wu, S., Liu, M., Wang, L., Huang, X., Li, F., Wu, W., Xu, Y., Zhao, Z., Xia, Y., Wang, Y., Yang, Y., Wang, W., Zhou, H., & Cao, M. (2024). Evaluation of the Efficacy of Chinese Inactivated COVID-19 Vaccines against the Delta Variant in the Nanjing Outbreak: A Cohort Study. Journal of Respiratory Biology and Translational Medicine. https://doi.org/10.70322/jrbtm.2024.10016
Vancouver
Liu F, Wu S, Liu M, Wang L, Huang X, Li F, et al. Evaluation of the Efficacy of Chinese Inactivated COVID-19 Vaccines against the Delta Variant in the Nanjing Outbreak: A Cohort Study. Journal of Respiratory Biology and Translational Medicine. 2024. doi:10.70322/jrbtm.2024.10016
BibTeX
@article{Liu2024,
author = {Liu, Fuqun and Wu, Shufei and Liu, Mengying and Wang, Lili and Huang, Xinmei and Li, Fuchao and Wu, Weihua and Xu, Ying and Zhao, Zhigang and Xia, Yangyang and Wang, Yujuan and Yang, Yue and Wang, Wei and Zhou, Haisen and Cao, Mengshu},
title = {Evaluation of the Efficacy of Chinese Inactivated COVID-19 Vaccines against the Delta Variant in the Nanjing Outbreak: A Cohort Study},
journal = {Journal of Respiratory Biology and Translational Medicine},
year = {2024},
doi = {10.70322/jrbtm.2024.10016}
}
EUVIMED